z-logo
Premium
Low‐risk transfusion‐related acute lung injury donor strategies and the impact on the onset of transfusion‐related acute lung injury: a meta‐analysis
Author(s) -
Müller Marcella C.A.,
Stein Danielle,
Binnekade Jan M.,
Rhenen Dick J.,
Vlaar Alexander P.J.
Publication year - 2015
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/trf.12816
Subject(s) - transfusion related acute lung injury , medicine , odds ratio , confidence interval , subgroup analysis , blood transfusion , meta analysis , intensive care medicine , lung , pulmonary edema
Background Transfusion‐related acute lung injury ( TRALI ) is the leading cause of transfusion‐related mortality. In the past decade blood banks have implemented low‐risk TRALI donor strategies, including a male‐only donor policy for plasma‐containing blood products to prevent onset of TRALI . We performed a meta‐analysis to determine whether use of low‐risk TRALI donor strategies for plasma indeed reduces onset of TRALI . Study Design and Methods We searched MEDLINE and C ochrane C entral R egister of C ontrolled T rials from J anuary 1995 up to J anuary 2013. Two reviewers independently extracted data on study characteristics, methods, and outcomes. Primary endpoint was onset of TRALI . Subgroup analyses were performed for patient populations prone to develop TRALI and general patient populations. Results Ten articles were included. Meta‐analysis using a random‐effects model taking into account all transfused products showed a significant reduction for the risk of TRALI after implementation of low‐risk TRALI donor strategies (odds ratio [ OR ], 0.61; 95% confidence interval [ CI ], 0.42‐0.88). Data from patient populations prone to develop TRALI showed a significant reduction of TRALI risk ( OR , 0.51; 95% CI , 0.29‐0.90), while data from general patient populations showed a similar nonsignificant trend ( OR , 0.66; 95% CI , 0.40‐1.09). Results were similar when taking only plasma products into account ( OR , 0.62; 95% CI , 0.42‐0.92). Conclusion The introduction of low‐risk TRALI donor strategies for plasma‐containing products results in a reduction of TRALI .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom